A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma
| Image |  |
|---|---|
| Description | scientific article published on 20 May 2020 |
| Author/s |
author: Shilpa Alekar Annick Desjardins Andrew B Lassman Timothy F. Cloughesy |
| Publication date | May 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |